Insider Transactions Reported by 9 Insiders of Sonoma Pharmaceuticals, Inc.

Symbol
SNOA on Nasdaq
Location
Boulder, CO

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Sonoma Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vanessa Jacoby Director 28 Jan 2026
Bruce Thornton Executive VP and COO 19 Jun 2025
John Mclaughlin Director 02 Jan 2026
Chad N. White Chief Financial Officer 29 Dec 2022
Jerome J. Dvonch Chief Financial Officer 02 Jan 2026
Philippe Weigerstorfer Director 02 Jan 2026
Amy Moss Trombly Chief Executive Officer 02 Jan 2026
Jay E. Birnbaum Director 02 Jan 2026
John Dal Poggetto Controller 02 Jan 2026

Recent Insider Transactions by Companies or Individuals for Sonoma Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Philippe Weigerstorfer SNOA Stock option (right to buy) Award 100% 10,000 20,001 02 Jan 2026 Direct
Amy Moss Trombly SNOA Restricted Stock Units Award 31.1% 10,000 42,185 02 Jan 2026 Direct
John Mclaughlin SNOA Stock option (right to buy) Award 100% 10,000 20,001 02 Jan 2026 Direct
Jerome J. Dvonch SNOA Restricted Stock Units Award 17% 5,000 34,391 02 Jan 2026 Direct
John Dal Poggetto SNOA Restricted Stock Units Award 24.7% 5,000 25,250 02 Jan 2026 Direct
Jay E. Birnbaum SNOA Stock option (right to buy) Award 100% 10,000 20,001 02 Jan 2026 Direct
Bruce Thornton SNOA Restricted Stock Units Award 72.2% 13,500 32,191 19 Jun 2025 Direct
John Dal Poggetto SNOA Restricted Stock Units Award 97.6% 10,000 20,250 19 Jun 2025 Direct
Jerome J. Dvonch SNOA Restricted Stock Units Award 112.4% 13,500 25,515 19 Jun 2025 Direct
Amy Moss Trombly SNOA Restricted Stock Units Award 72.2% 13,500 32,185 19 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.